HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Martin, R. J. Articles by Kraft, M. Search for Related Content PubMed PubMed Citation Articles by Martin, R. J. Articles by Kraft, M.

Introduction^*

Asthma in the New Millennium

^* From the National Jewish Medical and Research Center, University of Colorado Health Science Center, Denver, CO.

Correspondence to: Richard J. Martin, MD, National Jewish Medical and Research Center, University of Colorado Health Science Center, 1400 Jackson St, Denver, CO 80206.

45th Annual Thomas L. Petty Aspen Lung Conference was held June 5 to 8, 2002. The title the conference was "Asthma in the New Millennium." In planning this meeting, the organizers realized that the "explosion" of new information in regard to the pathophysiology and therapy for asthma would bring cutting edge scientific exchange throughout the sessions. This Aspen Lung Conference was planned with an emphasis on the basic and translational sciences, but also included new and novel therapies for asthma. The conference attendance reached another all-time high, which included scientists from 13 different countries. This, indeed, led to the excellent exchange of ideas and new information at an exceptionally high level.

The state-of-the-art asthma presentations focused on the biology of inflammation, the distal lung, functional consequences of airway structural changes, genetics/genomics, the epithelium, infection and asthma, airway smooth muscle, nocturnal asthma, severe asthma, bronchial hyperresponsiveness, airway remodeling, pediatric aspects, and new and exploratory therapies. There were a large number of high-quality poster presentations and 19 oral abstract presentations covering a variety of novel and late-breaking research. Always stressed at the Aspen Lung Conference are the discussion sessions after the state-of-the-art and abstract presentations. The interactions were always lively and challenging. The conference summarizer, Jeffrey M. Drazen, MD, eloquently put all this information together and challenged all of us to define asthma phenotypes and genotypes for better future therapies.

	Acknowledgements

 
We thank the Francis Family Foundation for their continued support of the Parker B. Francis Lectureship. We also greatly appreciate the generous support of all the sponsors of this year’s conference.

This Article Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Martin, R. J. Articles by Kraft, M. Search for Related Content PubMed PubMed Citation Articles by Martin, R. J. Articles by Kraft, M.